Electronic Clinical Outcome Assessment (eCOA) Solutions Market By Delivery Mode (On-premise, and Web & Cloud-based). By End-User Outlook (Hospitals/Healthcare providers, CROs, Pharmaceutical and Biotechnology Firms, Medical Device Companies, and Others)

Electronic Clinical Outcome Assessment (eCOA) Solutions Market Overview

The major factors driving their market expansion are increased regulatory compliance among industrial researchers, growing public-private investments in clinical research, a growing need for improved data standardization and collection aimed at early regulatory approval, and an expansion of the end-user base across major countries. An electronic clinical outcome assessment system is one that can monitor a patient's mental state, symptoms, and sickness prognosis (eCOA). The two fundamental components of eCOA systems are electronic diaries and electronic Patient Reported Outcomes (ePRO). These components serve as the support systems for ePRO. Compliance rates in all sorts of clinical outcome assessment system applications are exceptionally high, easing research operations.

The high demand for clinical trials in emerging markets, the pharmaceutical industry's high R&D spending, during the research period, the rising frequency of illnesses, and the change from manual data interpretation to real-time data analysis are likely to provide considerable development potential for global competitors. Furthermore, regulatory bodies have increasingly emphasized the importance of analyzing broader aspects of patient well-being in order to better characterize therapeutic gain. As a result, clinical outcome assessments (COAs) are increasingly being utilized to quantify the impact of various chronic disease treatments. In some cases, these have played a significant influence in medication regulatory approval. Additionally, the introduction of new services into the market will contribute to its expansion. With the tremendous development of the healthcare business, the demand for R&D to create breakthrough treatments and pharmaceuticals is expanding. The growing number of research investigations necessitates the development of a centralized data collection system. As a result, all of the aforementioned factors would fuel product demand during the projection period.

Market Size

According to Business Intelligence Insights “Electronic Clinical Outcome Assessment (eCOA) Solutions Market is expected to grow from USD 1,182.5 million in 2021 to USD 3,349.5  million by 2030, at a CAGR of 13.9% during the forecast period 2022-2030

Covid -19 Impact Analysis

The ongoing COVID-19 epidemic is a major public health hazard that is wreaking havoc on towns, industries, enterprises, and people all over the world. The immediate and direct potential impact of COVID-19 has already resulted in the loss of millions of lives and a significant increase in healthcare costs. Medical monitoring and safety reporting are crucial because various potential treatments were explored before the introduction of vaccines and used to treat the coronavirus-induced infection. As a result, demand for electronic clinical outcome assessment solutions has surged and is anticipated to rise more in the near future. As a result, the pandemic aided in the digitalization of clinical trials. Many sponsors, biopharma companies, medical device companies, and contract research organizations (CROs) began using eClinical solutions to collect data, manage it, and derive meaningful insights effectively and remotely. eCOAs allows for the remote collecting of patient data. As a result of the increased number of clinical studies due to the repurposing of various medications, the demand for electronic clinical outcome assessment solutions is predicted to rise.

Market Dynamics

• Drivers

• Large pharmaceutical and biopharmaceutical companies are increasingly outsourcing clinical trial studies.
• Growing Interest in Cloud-Based Services

• Restraints

• Concerns about data security and privacy
• High Implementation Costs

Segmentation Insights

Web & Cloud-based categories dominated the market with a major share of the market share

Cloud-based solutions are relatively newer approaches that are largely adopted by enterprises that lack the necessary internal infrastructure. These programs are less expensive to install than other systems. Furthermore, these products eliminate the need for in-house maintenance, which is most likely the primary factor driving their increased demand. Because all information (study protocols, patient data, outcomes, etc.) is stored in a central location and maintained by a third-party service provider, cloud-based systems are ideal for complex, multi-site clinical studies. Increasing the use of these platforms by pharmaceutical corporations and contract research organizations is propelling the segment.

CROs category dominated the market with a major share of the market share

Clinical research organizations (CROs) are businesses that hire individuals to conduct clinical studies on behalf of pharmaceutical corporations. Electronic Clinical Outcome Assessment (eCOA) solutions assist these CROs in enhancing the quality and efficiency of clinical trial processes while lowering patient recruiting expenses. With an electronic data capture system, these CROs can reduce the time necessary for patient enrollment by automating their jobs with accurate algorithms that enable speedier decision-making without the need for manual intervention.

By Delivery Mode

• On-premise
• Web & Cloud-based

By End-User

• Hospitals/Healthcare providers
• CROs
• Pharmaceutical and Biotechnology Firms
• Medical Device Companies
• Others

By Region

•    North America
o    U.S.
o    Canada

•    Europe 
o    Germany
o    U.K.
o    France
o    Italy
o    Spain
o    Rest of Europe

•    Asia Pacific 
o    China
o    India
o    Japan
o    Rest of Asia Pacific

•    Latin America 
o    Brazil
o    Mexico
o    Rest of Latin America

•    Middle East and Africa 
o    UAE
o    South Africa
o    Rest of Middle East and Africa (MEA)

Key Players

List of Key Players in the Global Electronic Clinical Outcome Assessment (eCOA) Solutions Market:

• IBM
• IQVIA Inc.
• Medidata SolutionsInc.
• Clario; ArisGlobal
• Signant Health
• TransPerfect
• Cloudbyz
• Climedo Health GmbH
• ClinCapture

Regional Insights

North America dominated the market with more than 40% of the market share

The market for electronic clinical outcome assessment solutions (eCOA) in North America is expected to develop rapidly due to an increase in clinical studies. Clinical trials are increasingly growing in the United States and Canada as the demand for drug research grows. Furthermore, ongoing improvements in eCOA methods and strategic alliances among leading market participants are contributing to the country's increased demand for these solutions. The United States obtained the largest revenue share of the market in North America. This is due to the widespread use of healthcare analytics services. Governments and non-profit groups are launching numerous projects to promote the use of eClinical platforms, which increases demand for these solutions.

Table

Report Attributes	Details
Market Size Value in 2021	USD1,182.5 Million
Market Size Value in 2030	USD 3,349.5 Million
Growth Rate	+13.9%
Base Year	2021
Forecast Period	2021-2030
Historical Data	2018-2020
Forecast Units	(USD Million)
Countries Covered	North America: U.S and Canada Europe: Germany, France, Italy, U.K, Spain, Russia, Rest of Europe APAC: China, Japan, South Korea, India, Australia, South East Asia, Rest of Asia Pacific Latin America: Brazil, Mexico Middle East And Africa: Saudi Arab, South Africa, UAE
Segments Covered	By Delivery Mode , By End-User , By Region
Competitive landscape	Leading companies, Competitive strategies and Consumer engagement scope
Customization is available	If our report does not contain the information you require, you can contact our experts to have segments created for you. Please contact us at sales@businessintelligence-insights.com if you have any questions

 

Frequently Asked Questions (FAQ):